Hanmi Pharm Co Ltd (128940) — Capital Reinvestment Ratio
Latest as of September 2025:
0.38x
Hanmi Pharm Co Ltd (128940) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩42.02 Billion) in capital expenditures (₩15.95 Billion). See cash generation quality of Hanmi Pharm Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.38x
Capex / Operating Cash Flow
Operating Cash Flow
₩42.02 Billion
KRW
Capital Expenditures
₩15.95 Billion
KRW
Data as of
Sep 2025
Most recent filing
Hanmi Pharm Co Ltd Capital Reinvestment Ratio (2010–2024)
This chart tracks Hanmi Pharm Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Hanmi Pharm Co Ltd (2010–2024)
Year-by-year Capital Reinvestment Ratio for Hanmi Pharm Co Ltd from 2010 to 2024. For live market cap and broader valuation context, see Hanmi Pharm Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | ₩193.49 Billion | ₩62.55 Billion | ▲ +60.1% |
| 2023 | 0.20x | ₩216.54 Billion | ₩43.74 Billion | ▲ +7.9% |
| 2022 | 0.19x | ₩162.27 Billion | ₩30.38 Billion | ▲ +89.5% |
| 2021 | 0.10x | ₩201.92 Billion | ₩19.95 Billion | ▼ -64.2% |
| 2020 | 0.28x | ₩151.53 Billion | ₩41.82 Billion | ▼ -97.9% |
| 2019 | 13.35x | ₩12.45 Billion | ₩166.13 Billion | ▲ +90.3% |
| 2018 | 7.02x | ₩25.98 Billion | ₩182.27 Billion | ▲ +1192.8% |
| 2016 | 0.54x | ₩412.97 Billion | ₩224.09 Billion | ▼ -54.4% |
| 2015 | 1.19x | ₩101.71 Billion | ₩121.07 Billion | ▲ +285.2% |
| 2013 | 0.31x | ₩85.99 Billion | ₩26.57 Billion | ▲ +40.9% |
| 2012 | 0.22x | ₩63.27 Billion | ₩13.87 Billion | ▼ -31.3% |
| 2011 | 0.32x | ₩61.30 Billion | ₩19.56 Billion | ▼ -70.5% |
| 2010 | 1.08x | ₩18.94 Billion | ₩20.46 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow